The Board of Regents of The University of Texas System;Merck Sharp & Dohme Corp.
发明人:
Fu, Tong-Ming,Wang, Dai,An, Zhiqiang
申请号：
AU2014278481
公开号：
AU2014278481A1
申请日:
2014.06.09
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention is directed to antigen binding proteins including, but not limited to, monoclonal antibodies and antigen binding fragments thereof, that specifically bind to and preferably neutralize human cytomegalovirus (CMV). Also encompassed by the invention are antigen binding proteins that have been humanized. The antigen binding proteins of the invention are useful as a therapeutic agent for treating and/or preventing CMV infections in a patient in need thereof.
